verified SJR 2,007 · Q1 • database Scopus / SJR & Web of Science indexed

United States · John Wiley and Sons Inc

workspace_premium Q1 — Psychiatry and Mental Health lock_open Open Access

Depression and Anxiety

Depression and Anxiety is a journal indexed in SJR in Psychiatry and Mental Health and Clinical Psychology with an H index of 168. It has a price of 3000 €. It has an SJR impact factor of 2,007 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,007.

Depression and Anxiety focuses its scope in these topics and keywords: anxiety, abuse, symptoms, depression, depressive, issue, adult, obsessivecompulsive, linking, alterations, ...

ISSN: 1091-4269

Publisher: John Wiley and Sons Inc

Category: Psychiatry and Mental Health

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

2,007 Q1

H-index 168

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.000 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,007

H-index

168

Docs (year)

Docs 3y

229

Total refs

4908

Cites 3y

1268

Citable 3y

226

Cites/Doc 2y

3.64

Ref/Doc

62.13

Immediate OA

3000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bipolar disorders. Basic mechanisms and therapeutic implications

Uncoupling of serotonergic and noradrenergic systems in depression: Preliminary evidence from continuous cerebrospinal fluid sampling

Comparing primary and secondary generalized anxiety disorder in a long-term naturalistic study of anxiety disorders

Community correlates of outcomes in subjects with panic attacks

Clomipramine augmentation in treatment-resistant depression

Chronic inositol treatment reduces depression-like immobility of Flinders Sensitive Line rats in the forced swim test

Child and parent reports of childhood anxiety: Differences in coping styles

Characterizing selective mutism: Is it more than social anxiety?

CCK-antagonists in a rat exposed to acute stress: Implication for anxiety associated with post-traumatic stress disorder

Buspirone potentiation of antidepressants in the treatment of PTSD

Bright light augments antidepressant effects of medication and wake therapy

Brain basics: An integrated biological approach to understanding and assessing human behavior

SHOW MORE ARTICLES

Bipolar medications, mechanisms of action

A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills

Bipolar depression: An underestimated treatment challenge

Anxiolytic-like effect of group housing on stress-induced behavior in rats

Anxiety Patients Show Reduced Working Memory Related dlPFC Activation During Safety and Threat

Anxiety across the life span: Epidemiological evidence and treatment data

AN EXAMINATION OF PTSD SYMPTOMS AS A MEDIATOR OF THE RELATIONSHIP BETWEEN TRAUMA HISTORY CHARACTERISTICS AND PHYSICAL HEALTH FOLLOWING A MOTOR VEHICLE ACCIDENT

Alternative approaches to refractory depression in bipolar illness

Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review

Accelerating response in geriatric depression: A pilot study combining sleep deprivation and paroxetine

A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression

A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: Comparing patients who recently discontinued an ssri with those on no recent antidepressant treatment

FAQs

Depression and Anxiety has an SJR of 2,007 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3000 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Depression and Anxiety is 22%.

Depression and Anxiety

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Depression and Anxiety?

What is the APC / publication cost?

What is the acceptance rate?